STOCK TITAN

[6-K] Haleon plc Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Haleon plc reports a purchase of 2,318,700 ordinary shares under the second tranche of its share buyback programme. The trades occurred on the London Stock Exchange/CBOE (UK)/CXE on 25 September 2025 with reported trade price points shown as 329.7000, 325.9000 and a weighted average of 327.8536. The Company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares of £0.01 each, of which 38,908,103 are held as treasury shares, leaving 8,913,445,545 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided RNS link and on the Company website.

Haleon plc comunica l'acquisto di 2.318.700 azioni ordinarie nell'ambito della seconda tranche del programma di riacquisto azionario. Le operazioni si sono svolte presso la London Stock Exchange/CBOE (UK)/CXE il 25 settembre 2025, con i prezzi di lavorazione riportati come 329.7000, 325.9000 e una media ponderata di 327.8536. L'azienda intende detenere le azioni acquisite come azioni tesoreria. Dopo la regolamentazione, il capitale sociale registrato è di 8.952.353.648 azioni ordinarie di £0,01 ciascuna, di cui 38.908.103 sono detenute come azioni tesoriate, lasciando 8.913.445.545 azioni ordinarie con diritto di voto. Un completo dettaglio delle singole operazioni è disponibile tramite il link RNS fornito e sul sito della Società.

Haleon plc informa de la compra de 2.318.700 acciones ordinarias dentro de la segunda tramo de su programa de recompra de acciones. Las operaciones se realizaron en London Stock Exchange/CBOE (UK)/CXE el 25 de septiembre de 2025, con los puntos de precio de operación reportados como 329.7000, 325.9000 y un promedio ponderado de 327.8536. La Compañía tiene la intención de mantener las acciones adquiridas como acciones en tesorería. Tras la liquidación, el capital social registrado es de 8.952.353.648 acciones ordinarias de £0.01 cada una, de las cuales 38.908.103 se mantienen como acciones en tesorería, quedando 8.913.445.545 acciones ordinarias con derecho de voto. Un desglose completo de las operaciones individuales está disponible a través del enlace RNS proporcionado y en el sitio web de la Compañía.

Haleon plc가 자사 2차 주주가치 환매 프로그램의 2,318,700주의 보통주를 매입했다고 발표합니다. 거래는 2025년 9월 25일에 런던 증권 거래소/LSE(CBOE UK)/CXE에서 발생했으며 보고된 거래가격은 329.7000, 325.9000, 가중평균은 327.8536으로 표시되었습니다. 회사는 매입 주식을 재무주(treasury shares)로 보유할 예정입니다. 결제 후 등록된 자본은 각 주당 £0.01인 8,952,353,648주의 보통주이고, 그 중 38,908,103주재무주로 보유되어 의결권이 있는 보통주8,913,445,545주 남습니다. 각 거래의 전체 내역은 제공된 RNS 링크 및 회사 웹사이트에서 확인할 수 있습니다.

Haleon plc annonce l'achat de 2 318 700 actions ordinaires dans le cadre de la deuxième tranche de son programme de rachat d'actions. Les opérations ont eu lieu sur la London Stock Exchange/CBOE (UK)/CXE le 25 septembre 2025, avec les niveaux de prix de transaction rapportés comme 329.7000, 325.9000 et une moyenne pondérée de 327.8536. La société a l'intention de détenir les actions achetées comme actions propres (treasury shares). Après règlement, le capital social enregistré est de 8 952 353 648 actions ordinaires de £0,01 chacune, dont 38 908 103 sont détenues comme actions propres, laissant 8 913 445 545 actions ordinaires avec droit de vote. Une répartition complète de chaque opération est disponible via le lien RNS fourni et sur le site de la Société.

Haleon plc meldet den Erwerb von 2.318.700 Stammaktien im Rahmen der zweiten Tranche seines Aktienrückkaufprogramms. Die Transaktionen fanden am 25. September 2025 an der London Stock Exchange/CBOE (UK)/CXE statt und gemeldete Handelspreise lauten 329.7000, 325.9000 sowie ein gewichteter Durchschnitt von 327.8536. Das Unternehmen beabsichtigt, die erworbenen Aktien als Treasury Shares zu halten. Nach Abwicklung beträgt das registrierte Aktienkapital 8.952.353.648 Stammaktien zu je £0,01, davon 38.908.103 als Treasury Shares gehalten, sodass 8.913.445.545 stimmberechtigte Stammaktien verbleiben. Eine vollständige Aufschlüsselung der einzelnen Trades ist über den bereitgestellten RNS-Link und die Website des Unternehmens verfügbar.

Haleon plc تعلن عن شراء 2,318,700 سهمًا عاديًا ضمن الدفعة الثانية من برنامج إعادة شراء الأسهم. التداولات جرت على بورصة لندن/London Stock Exchange/CBOE (UK)/CXE في 25 سبتمبر 2025 مع نقاط سعر التداول المبلغ عنها وهي 329.7000، 325.9000 وبمتوسط موزون قدره 327.8536. تعتزم الشركة الاحتفاظ بالأسهم المشترية كـ أسهم خزانة. بعد التسوية، رأس المال المسجل هو 8,952,353,648 سهمًا عاديًا بقيمة £0.01 للسهم الواحد، من بينها 38,908,103 مُحتفظ بها كـ أسهم خزينة، مع إبقاء 8,913,445,545 سهمًا عاديًا الصوتية بحق التصويت. يمكن الاطلاع على تفصيل كامل للصفقات الفردية عبر رابط RNS المقدم وعلى موقع الشركة.

Haleon plc 报告在其第二批股权回购计划中购买了 2,318,700 股普通股。交易在 2025 年 9 月 25 日于伦敦证券交易所/CBOE (UK)/CXE 进行,报道的交易价格点为 329.7000325.9000,加权平均为 327.8536。公司计划将所购股票作为 库藏股持有。结算后,登记的注册股本为 8,952,353,648 股普通股,面值为每股 £0.01,其中 38,908,103 作为 库藏股,剩余具投票权的普通股为 8,913,445,545 股。有关各笔交易的完整明细可通过提供的 RNS 链接及公司网站查看。

Positive
  • Executed buyback of 2,318,700 shares under the second tranche of the announced programme
  • Purchased shares will be held as treasury shares, with the company explicitly stating intention
  • Updated registered capital and voting share counts provided, allowing shareholders to determine notification thresholds
  • Full trade breakdown published via RNS and the company website for transparency
Negative
  • None.

Insights

TL;DR: Haleon executed a tranche of its announced buyback, reducing outstanding voting shares and adding treasury stock.

The announcement confirms execution of 2,318,700 shares purchased under the second tranche of the buyback programme, with trade data published for transparency. Retaining the shares as treasury stock means they are not cancelled and remain part of registered capital but are excluded from voting rights totals. The filing provides updated counts of registered capital, treasury shares, and voting shares, and directs investors to a full trade breakdown via RNS and the company website. This is a routine corporate action consistent with share repurchase programmes designed to manage capital structure.

TL;DR: The company disclosed purchase details and updated voting share totals, meeting Market Abuse Regulation disclosure norms.

The Form 6-K furnishes required transparency under the Market Abuse Regulation by confirming the volume of shares bought, the intention to hold them as treasury shares, and the updated counts for registered capital and voting shares. The filing references an external full trade breakdown, fulfilling the disclosure obligation to allow shareholders to assess notification thresholds under the FCA's rules. The information is procedural and complies with public disclosure standards for buybacks.

Haleon plc comunica l'acquisto di 2.318.700 azioni ordinarie nell'ambito della seconda tranche del programma di riacquisto azionario. Le operazioni si sono svolte presso la London Stock Exchange/CBOE (UK)/CXE il 25 settembre 2025, con i prezzi di lavorazione riportati come 329.7000, 325.9000 e una media ponderata di 327.8536. L'azienda intende detenere le azioni acquisite come azioni tesoreria. Dopo la regolamentazione, il capitale sociale registrato è di 8.952.353.648 azioni ordinarie di £0,01 ciascuna, di cui 38.908.103 sono detenute come azioni tesoriate, lasciando 8.913.445.545 azioni ordinarie con diritto di voto. Un completo dettaglio delle singole operazioni è disponibile tramite il link RNS fornito e sul sito della Società.

Haleon plc informa de la compra de 2.318.700 acciones ordinarias dentro de la segunda tramo de su programa de recompra de acciones. Las operaciones se realizaron en London Stock Exchange/CBOE (UK)/CXE el 25 de septiembre de 2025, con los puntos de precio de operación reportados como 329.7000, 325.9000 y un promedio ponderado de 327.8536. La Compañía tiene la intención de mantener las acciones adquiridas como acciones en tesorería. Tras la liquidación, el capital social registrado es de 8.952.353.648 acciones ordinarias de £0.01 cada una, de las cuales 38.908.103 se mantienen como acciones en tesorería, quedando 8.913.445.545 acciones ordinarias con derecho de voto. Un desglose completo de las operaciones individuales está disponible a través del enlace RNS proporcionado y en el sitio web de la Compañía.

Haleon plc가 자사 2차 주주가치 환매 프로그램의 2,318,700주의 보통주를 매입했다고 발표합니다. 거래는 2025년 9월 25일에 런던 증권 거래소/LSE(CBOE UK)/CXE에서 발생했으며 보고된 거래가격은 329.7000, 325.9000, 가중평균은 327.8536으로 표시되었습니다. 회사는 매입 주식을 재무주(treasury shares)로 보유할 예정입니다. 결제 후 등록된 자본은 각 주당 £0.01인 8,952,353,648주의 보통주이고, 그 중 38,908,103주재무주로 보유되어 의결권이 있는 보통주8,913,445,545주 남습니다. 각 거래의 전체 내역은 제공된 RNS 링크 및 회사 웹사이트에서 확인할 수 있습니다.

Haleon plc annonce l'achat de 2 318 700 actions ordinaires dans le cadre de la deuxième tranche de son programme de rachat d'actions. Les opérations ont eu lieu sur la London Stock Exchange/CBOE (UK)/CXE le 25 septembre 2025, avec les niveaux de prix de transaction rapportés comme 329.7000, 325.9000 et une moyenne pondérée de 327.8536. La société a l'intention de détenir les actions achetées comme actions propres (treasury shares). Après règlement, le capital social enregistré est de 8 952 353 648 actions ordinaires de £0,01 chacune, dont 38 908 103 sont détenues comme actions propres, laissant 8 913 445 545 actions ordinaires avec droit de vote. Une répartition complète de chaque opération est disponible via le lien RNS fourni et sur le site de la Société.

Haleon plc meldet den Erwerb von 2.318.700 Stammaktien im Rahmen der zweiten Tranche seines Aktienrückkaufprogramms. Die Transaktionen fanden am 25. September 2025 an der London Stock Exchange/CBOE (UK)/CXE statt und gemeldete Handelspreise lauten 329.7000, 325.9000 sowie ein gewichteter Durchschnitt von 327.8536. Das Unternehmen beabsichtigt, die erworbenen Aktien als Treasury Shares zu halten. Nach Abwicklung beträgt das registrierte Aktienkapital 8.952.353.648 Stammaktien zu je £0,01, davon 38.908.103 als Treasury Shares gehalten, sodass 8.913.445.545 stimmberechtigte Stammaktien verbleiben. Eine vollständige Aufschlüsselung der einzelnen Trades ist über den bereitgestellten RNS-Link und die Website des Unternehmens verfügbar.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of September 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
26 September 2025 - “Transaction in Own Shares”
 
 
99.1
 
 
 
Haleon plc: Transaction in own shares
 
26 September 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 2,318,700 ordinary shares of £0.01 each in the Company (the "Shares") under the second tranche of its share buyback programme announced on 31 July 2025.
 
 
London Stock Exchange
CBOE (UK)/BXE
CBOE (UK)/CXE
Date of purchase:
25 September 2025
25 September 2025
25 September 2025
Number of Shares purchased:
2,318,700
-
-
Highest price paid per Share (p):
329.7000
-
-
Lowest price paid per Share (p):
325.9000
-
-
Volume weighted average price paid per Share (p):
327.8536
-
-
 
The Company intends to hold the purchased shares as treasury shares.
 
Following the settlement of the above, the Company's registered share capital is 8,952,353,648 ordinary shares of £0.01 each, of which 38,908,103 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,913,445,545 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/9003A_1-2025-9-25.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
 
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com
 
 
 
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: September 26, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

How many shares did Haleon (HLN) buy under the second tranche of the buyback?

The Company purchased 2,318,700 ordinary shares under the second tranche of its buyback programme.

Will Haleon cancel the repurchased shares or hold them as treasury shares?

The Company intends to hold the purchased shares as treasury shares.

What are Haleon's updated voting share totals after this buyback?

Following settlement, there are 8,913,445,545 ordinary shares with voting rights.

Where can I find the full breakdown of the individual trades?

A full breakdown is available at the RNS link provided in the announcement and on www.haleon.com/investors.

What is Haleon's registered share capital after the purchase?

Registered share capital is 8,952,353,648 ordinary shares of £0.01 each.
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

38.87B
4.47B
0.02%
12.85%
0.36%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
Weybridge